IP Group is an IP commercialization company specializing in evolving great ideas into world-changing businesses.
Business Model: B2B
Revenue: $316M
Employees: 51-200
Address: 25 Walbrook
City: London
State: england
Zip: EC4N 8AF
Country: GB
IP Group&s;s core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and create value out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group&s;s extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Contact Phone:
Contact Email:
Listed Exchange:
LSE
IPO Date:
11/5/2003
Ticker Symbol:
IPO
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2022 | Diffblue | Series A | 5.4M |
8/2018 | Genomics | Series B | 32.5M |
1/2020 | Instrumems | Seed Round | 3M |
5/2022 | MoA Technology | Series B | 0 |
3/2021 | Oxular | Series B | 37M |
4/2018 | Enterprise Therapeutics | Series B | 41.3M |
1/2019 | Featurespace | Venture Round | 0 |
11/2021 | Ultraleap | Series D | 80.9M |
5/2017 | Ultraleap | Series B | 23M |
3/2022 | VYTAL | Series A | 0 |
12/2016 | AccelerComm | Seed Round | - |
2/2019 | AccelerComm | Seed Round | 3.2M |
3/2016 | Mirriad | Series D | 15M |
10/2018 | Garrison Technology | Series B | 30.1M |
10/2019 | CareAlign | Pre Seed Round | 450k |
5/2020 | Navenio | Series A | 0 |
3/2012 | Seren Photonics | Venture Round | 2.8M |
12/2017 | Navenio | Funding Round | 7.7M |
1/2021 | Carisma Therapeutics | Series B | 0 |
2/2018 | Econic Technologies | Venture Round | 9.7M |
3/2023 | Intrinsic Semiconductor Technologies | Venture Round | 0 |
2/2023 | Quantum Motion | Series B | 0 |
5/2022 | SLAMcore | Series A | 0 |
5/2020 | Quantum Motion Technologies | Series A | 9.8M |
9/2022 | Innervace | Series A | 40M |
6/2018 | Carisma Therapeutics | Series A | 0 |
8/2010 | Chamelic | Venture Round | 1.6M |
12/2022 | Pulmocide | Series C | 0 |
8/2013 | Chadex | Seed Round | 156.5k |
9/2014 | Blooie | Seed Round | 324.6k |
12/2017 | Oxehealth | Venture Round | 4M |
6/2017 | Creavo Medical Technologies | Series B | 17.3M |
2/2022 | First Light Fusion | Series C | 45M |
10/2011 | Givey | Seed Round | 25.4k |
10/2011 | Usable HQ | Seed Round | 33.2k |
10/2013 | Verticly | Seed Round | 36.5k |
6/2020 | Oxford Ionics | Seed Round | 3.4M |
5/2014 | Oxehealth | Venture Round | 3.4M |
9/2012 | Inquirely | Seed Round | 31.6k |
10/2015 | SpecifiedBy | Seed Round | 537.4k |
9/2012 | Social Rithmic | Seed Round | 36.5k |
11/2021 | ieso | Series B | 0 |
7/2012 | CatalySystems | Seed Round | 774.5k |
2/2017 | Refract | Seed Round | 0 |
10/2019 | Inflowmatix | Series B | 0 |
3/2018 | OxSyBio | Series A | 13.9M |
4/2015 | Anacail | Series A | 3M |
8/2009 | Surrey NanoSystems | Venture Round | 4.1M |
1/2011 | Crysalin | Series A | 2.4M |
11/2006 | Structure Vision | Venture Round | 572k |
10/2014 | Perpetuum | Series C | - |
7/2015 | Avacta Group | Post-IPO Equity | 34.2M |
12/2014 | MathChat | Seed Round | 43.2k |
7/2016 | Uniphy Ltd | Seed Round | 558.4k |
7/2014 | Givey | Seed Round | 514.4k |
2/2018 | Ditto | Venture Round | 5.5M |
9/2012 | Oxehealth | Seed Round | 812.3k |
2/2012 | Givey | Seed Round | 142.6k |
3/2014 | Websand | Seed Round | 266.6k |
12/2011 | Durham Graphene Science | Seed Round | 940.6k |
2/2014 | MathChat | Seed Round | 141.5k |
3/2014 | Moltin | Seed Round | 157.8k |
12/2012 | Givey | Seed Round | 923.7k |
4/2014 | SpecifiedBy | Seed Round | 207.8k |
11/2013 | Actual Experience | Funding Round | 6.4M |
5/2020 | Ibex Innovations | Venture Round | 0 |
4/2014 | OxSyBio | Seed Round | 1.7M |
11/2014 | Eight19 | Venture Round | 1.6M |
1/2016 | Zeetta Networks | Seed Round | 2M |
1/2014 | Websand | Seed Round | 265.1k |
6/2017 | Zilico | Venture Round | - |
10/2013 | Twinklr | Seed Round | 36.3k |
8/2015 | First Light Fusion | Venture Round | 35.4M |
9/2012 | Yippee | Seed Round | 36.5k |
8/2022 | Somalytics | Seed Round | 1.9M |
11/2010 | Xeros | Venture Round | 5.6M |
12/2018 | Genomics | Series B | 9.1M |
1/2016 | Mixergy Ltd. | Seed Round | - |
5/2006 | Oxford Nanopore Technologies | Series A | 14.5M |
11/2014 | Ultraleap | Seed Round | 942.4k |
11/2015 | Ultraleap | Series A | 15.6M |
9/2012 | Steelyard | Seed Round | 22.5k |
10/2012 | Adludio | Seed Round | 36.1k |
1/2007 | Tissue Regenix | Venture Round | 1.3M |
3/2013 | Xeros | Venture Round | 0 |
11/2012 | Magnomatics | Venture Round | 0 |
10/2011 | ArtSpotter | Seed Round | 30.8k |
9/2018 | Oxbotica | Venture Round | 18.4M |
10/2019 | Growave.ag | Seed | 900k |
3/2015 | Azellon Cell Therapeutics | Venture Round | 814.3k |
11/2011 | Azellon Cell Therapeutics | Venture Round | 1M |
4/2013 | Deltasight | Seed Round | 200k |
7/2017 | Eight19 | Venture Round | 0 |
12/2018 | Ultraleap | Series C | 0 |
6/2019 | Exyn Technologies | Series A | 0 |
2/2012 | CrowdIPR | Seed Round | 134.3k |
10/2013 | Websand | Seed Round | 44.4k |
10/2013 | Papertrail.io | Seed Round | 36.3k |
10/2011 | RentMama | Seed Round | 33.2k |
11/2013 | Exonate | Seed Round | 638.2k |
4/2022 | Gripable | Series A | 0 |
2/2019 | C-Capture | Venture Round | 4.6M |
12/2014 | MathChat | Seed Round | 412.1k |
10/2013 | Bizpora | Seed Round | 44.4k |
11/2009 | Polar OLED | Venture Round | - |
9/2012 | OrderHarmony | Seed Round | 36.5k |
12/2014 | Exyn Technologies | Seed Round | 1M |
10/2011 | Odimax | Seed Round | 33.2k |
2/2013 | OrderHarmony | Seed Round | 137.1k |
12/2016 | Microbiotica | Seed Round | 9.9M |
5/2022 | Ankere Therapeutics | Seed Round | 0 |
4/2022 | Kynos Therapeutics | Seed Round | 0 |
3/2022 | Alimetry | Series A | 0 |
2/2012 | Blooie | Seed Round | 142.6k |
6/2012 | Iksuda Therapeutics | Venture Round | 3.1M |
12/2016 | Exyn Technologies | Seed Round | 2.5M |
12/2010 | Seren Photonics | Seed Round | 741.3k |
7/2018 | Spirea Ltd. | Pre Seed Round | - |
1/2019 | AudioScenic | Seed Round | 637.7k |
11/2017 | Quantum Motion Technologies | Seed Round | - |
9/2022 | AMSL Aero | Series B | 23M |
8/2020 | Bramble Energy | Series A | 6.5M |
8/2018 | Dukosi | Venture Round | 2.4M |
3/2021 | Intrinsic Semiconductor Technologies | Seed Round | 1.9M |
8/2021 | Arkivum | Private Equity Round | 2.2M |
10/2012 | Earsoft | Seed Round | 44.4k |
9/2015 | Seren Photonics | Venture Round | 1.5M |
2/2012 | ArtSpotter | Seed Round | 142.2k |
7/2020 | MISSION Therapeutics | Venture Round | 15M |
8/2012 | Clyde Biosciences | Seed Round | - |
3/2013 | Blooie | Seed Round | 170.5k |
11/2018 | Ibex Innovations | Venture Round | 1.3M |
10/2011 | Blooie | Seed Round | 25.4k |
2/2012 | Usable HQ | Seed Round | 142.2k |
7/2016 | Instrumems | Seed Round | 1M |
10/2018 | Yoyo Wallet | Series C | 30M |
11/2014 | Genomics | Series A | 16.2M |
10/2013 | Moltin | Seed Round | 44.4k |
7/2015 | Oxford Nanopore Technologies | Venture Round | 108.9M |
8/2012 | MedaPhor | Funding Round | 1.7M |
6/2019 | Azuri Technologies | Corporate Round | 26M |
6/2017 | Carisma Therapeutics | Seed Round | - |
5/2021 | Oxford Nanopore Technologies | Venture Round | 270.8M |
3/2014 | SpecifiedBy | Seed Round | 148.6k |
5/2014 | Seren Photonics | Venture Round | 3.2M |
4/2020 | Alimetry | Seed Round | - |
4/2011 | Oxford Nanopore Technologies | Venture Round | 41.2M |
7/2011 | Oxyntix | Venture Round | 1M |
2/2022 | Bramble Energy | Series B | 47.4M |
10/2013 | SpecifiedBy | Seed Round | 36.4k |
3/2012 | Deltasight | Seed Round | 135k |
2/2017 | Dukosi | Series A | 2.5M |
7/2017 | Zeetta Networks | Seed Round | 2.1M |
2/2012 | Durham Graphene Science | Seed Round | 1.9M |
9/2013 | Ubiquigent | Seed Round | 804.7k |
10/2011 | CrowdIPR | Seed Round | 33.4k |
5/2010 | Karus Therapeutics | Seed Round | 1.1M |
6/2009 | Xeros | Seed Round | 1.5M |
12/2012 | Durham Graphene Science | Seed Round | 1.1M |
5/2022 | Abliva AB | Post-IPO Equity | 0 |
11/2020 | Econic Technologies | Debt Financing | 4.2M |
4/2019 | Aqdot | Series B | 7.9M |
2/2022 | Barocal | Seed Round | 0 |
2/2012 | TheySay | Corporate Round | 791.4k |
3/2022 | Aptatek Biosciences | Seed Round | 0 |
5/2005 | Oxford Nanopore Technologies | Seed Round | 891.5k |
5/2012 | Oxford Nanopore Technologies | Venture Round | 50.8M |
8/2014 | Oxford Nanopore Technologies | Venture Round | 58.8M |
12/2016 | Oxford Nanopore Technologies | Venture Round | 126.8M |
2/2013 | Social Rithmic | Seed Round | 137.1k |
3/2011 | Activiomics | Venture Round | 805k |
10/2011 | Skip a Blink | Seed Round | 25.4k |
12/2013 | Talivest | Seed Round | - |
3/2014 | Genomics | Seed Round | - |
4/2014 | Creavo Medical Technologies | Seed Round | 2.7M |
11/2020 | AudioScenic | Series A | 0 |
2/2016 | Stratium | Seed Round | 437.7k |
5/2010 | Karus Therapeutics | Venture Round | 1.1M |
4/2017 | Saw DX | Venture Round | 2.3M |
8/2005 | ACSIAN | Seed Round | 493.8k |
10/2015 | BOXARR | Seed Round | 3.1M |
12/2018 | import.io | Series B | 15.5M |
6/2017 | Alesi Surgical | Venture Round | 6.7M |
4/2018 | Crescendo Biologics | Series B | 0 |
9/2005 | Cerogenix | Seed Round | 675.4k |
10/2012 | Chadex | Seed Round | 36.1k |
8/2018 | Artios Pharma | Series B | 0 |
10/2010 | Iksuda Therapeutics | Venture Round | 795.5k |
12/2021 | Navenio | Venture Round | 0 |
4/2014 | Arkivum | Series B | 3.2M |
12/2021 | CANOPUS Networks | Series A | 7.1M |
10/2012 | Fantoo | Seed Round | 44.4k |
12/2013 | Ridee | Seed Round | 44.8k |
11/2016 | Arkivum | Series D | 3.7M |
1/2018 | Arkivum | Series E | 5.6M |
7/2015 | CatalySystems | Seed Round | 1.4M |
4/2014 | CatalySystems | Seed Round | 501.8k |
12/2017 | Spirea Ltd. | Pre Seed Round | - |
9/2013 | CatalySystems | Seed Round | 550.3k |
5/2019 | Ibex Innovations | Venture Round | 1.3M |
12/2013 | Blooie | Seed Round | 180.2k |
7/2021 | Artios Pharma | Series C | 0 |
2/2022 | Microbiotica | Series B | 0 |
7/2004 | Techtran Group | Venture Round | 3.7M |
8/2012 | Arkivum | Series A | 2.4M |
1/2020 | RFC Power | Seed Round | - |
3/2015 | Relitect | Seed Round | 1.1M |
2/2014 | Reframed.tv | Seed Round | 150.7k |
10/2013 | Reframed.tv | Seed Round | 44.5k |
11/2022 | Diffblue | Series A | 0 |
6/2016 | 8power | Seed Round | 941.7k |
7/2007 | TheraGenetics | Series A | 6M |
2/2012 | Odimax | Seed Round | 135k |
7/2011 | First Light Fusion | Venture Round | 1.6M |
12/2019 | Mixergy Ltd. | Series A | 0 |
5/2018 | Lorem Therapeutics | Seed Round | - |
2/2023 | AudioScenic | Series A | - |
5/2019 | Storm Therapeutics | Series A | 17.8M |
8/2020 | Mobilion Systems | Series B | 35M |
10/2019 | Kira Biotech | Series A | 20M |
6/2018 | Silicon MicroGravity | Venture Round | 7M |
12/2006 | Surrey NanoSystems | Seed Round | - |
8/2016 | Cambridge Innovation Capital | Venture Round | 75M |
11/2019 | Mobilion Systems | Series A | 15.4M |
2/2010 | Oxford Nanopore Technologies | Series C | 27.7M |
4/2023 | AccelerComm | Series B | 0 |
3/2019 | Inivata | Series B | 0 |
9/2020 | AccelerComm | Series A | 7.4M |
10/2015 | Dukosi | Venture Round | 1.8M |
4/2009 | Azellon Cell Therapeutics | Seed Round | 0 |
2/2013 | Earsoft | Seed Round | 228.6k |
3/2021 | Carisma Therapeutics | Series B | 0 |
1/2022 | Diffblue | Seed Round | 5.4M |
11/2011 | Arkivum | Seed Round | 1.3M |
5/2021 | Pulmocide | Series C | 0 |
12/2022 | Storm Therapeutics | Series B | 30M |
12/2014 | Dukosi | Venture Round | 1.6M |
2/2021 | C-Capture | Venture Round | 11.3M |
8/2014 | Diurnal Group | Venture Round | 10.1M |
11/2006 | Oxtox | Series A | 1.1M |
3/2008 | Oxford Nanopore Technologies | Series B | 19.9M |
1/2021 | Oxbotica | Series B | 0 |
8/2017 | Inductosense | Series A | 1.4M |
7/2021 | Mobilion Systems | Series C | 0 |
10/2014 | Intelligent Ultrasound | Venture Round | 2.1M |
12/2015 | Navenio | Seed Round | 2.6M |
9/2017 | Ionix Advanced Technologies | Venture Round | - |
10/2011 | Vibetrace | Seed Round | 25.6k |
2/2012 | Skip a Blink | Seed Round | 142.2k |
6/2007 | Xanic | Series A | 808k |
10/2013 | Oxford Nanopore Technologies | Venture Round | 0 |
3/2012 | Surrey NanoSystems | Series C | 7.1M |
9/2019 | WaveOptics | Series C | 13M |
7/2015 | Ionix Advanced Technologies | Series A | 3.1M |
3/2015 | Arkivum | Series C | 2.4M |
5/2014 | Oxehealth | Seed Round | 3.4M |
12/2018 | WaveOptics | Series C | 25M |
9/2012 | Karus Therapeutics | Series B | 7.6M |
3/2014 | Earsoft | Seed Round | 735.5k |
4/2013 | CrowdIPR | Seed Round | 198.2k |
5/2022 | Abliva AB | Post-IPO Equity | 0 |
5/2022 | MoA Technology | Series B | 0 |
5/2022 | Ankere Therapeutics | Seed Round | 0 |
5/2022 | SLAMcore | Series A | 0 |
4/2022 | Gripable | Series A | 0 |
4/2022 | Kynos Therapeutics | Seed Round | 0 |
3/2022 | Aptatek Biosciences | Seed Round | 0 |
3/2022 | VYTAL | Series A | 0 |
3/2022 | Alimetry | Series A | 0 |
2/2022 | Barocal | Seed Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|